Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Coley Pharmaceutical Group, Inc. (COLY)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/13/2008 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2008 |
SC 13G/A
| ZIFF ASSET MANAGEMENT LP reports a 0% stake in Coley Pharmaceutical Group, Inc. |
| 02/06/2008 |
SC 13G/A
| FRANKLIN RESOURCES INC reports a 0% stake in Coley Pharmaceutical Group, Inc. |
| 01/31/2008 |
4
| BATE KENNETH (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Unknown transaction of 21,834 options to buy
@ $1.15, valued at
$25.1k
|
|
| 01/25/2008 |
4
| Krieg Arthur M (SVP, R & D, Chief Scien. Off.) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Unknown transaction of 545,602 shares
@ $0
Unknown transaction of 5,240 shares
@ $0
Unknown transaction of 153,672 options to buy
@ $1.15, valued at
$176.7k
Unknown transaction of 13,646 options to buy
@ $1.15, valued at
$15.7k
Unknown transaction of 94,788 options to buy
@ $1.15, valued at
$109k
Unknown transaction of 55,000 options to buy
@ $3.13, valued at
$172.2k
|
|
| 01/25/2008 |
4
| Abdalian Charles H Jr (SVP, Finance and CFO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Unknown transaction of 52,402 options to buy
@ $1.15, valued at
$60.3k
Unknown transaction of 58,123 options to buy
@ $1.15, valued at
$66.8k
Unknown transaction of 40,000 options to buy
@ $3.13, valued at
$125.2k
Unknown transaction of 8,666 options to buy
@ $1.15, valued at
$10k
|
|
| 01/25/2008 |
4
| Massari Ferdinand E (Sr. VP of Drug Development) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Unknown transaction of 65,000 options to buy
@ $3.13, valued at
$203.5k
|
|
| 01/25/2008 |
4
| Bratzler Robert L (President and CEO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Unknown transaction of 308,697 shares
@ $0
Unknown transaction of 150,654 shares
@ $0
Unknown transaction of 356,987 options to buy
@ $1.15, valued at
$410.5k
Unknown transaction of 168,258 options to buy
@ $1.15, valued at
$193.5k
Unknown transaction of 70,000 options to buy
@ $3.13, valued at
$219.1k
|
|
| 01/25/2008 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Unknown transaction of 21,834 options to buy
@ $1.15, valued at
$25.1k
|
|
| 01/25/2008 |
4
| Langlois Patrick (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Unknown transaction of 21,834 options to buy
@ $1.15, valued at
$25.1k
|
|
| 01/25/2008 |
4
| Karobath Manfred E (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Unknown transaction of 135,783 shares
@ $0
Unknown transaction of 3,753 options to buy
@ $1.15, valued at
$4.3k
Unknown transaction of 4,549 options to buy
@ $1.15, valued at
$5.2k
Unknown transaction of 11,358 options to buy
@ $5.64, valued at
$64.1k
|
|
| 01/04/2008 |
8-K
| Quarterly results |
| 01/04/2008 |
SC 13D
| PFIZER INC has filed a Schedule 13D for Coley Pharmaceutical Group, Inc. |
| 01/03/2008 |
SC 13D/A
| GAMCO INVESTORS, INC. ET AL reports a 0% stake in Coley Pharmaceutical Group, Inc. |
| 12/21/2007 |
SC 13D
| GAMCO INVESTORS, INC. ET AL reports a 3.8% stake in Coley Pharmaceutical Group, Inc. |
| 12/14/2007 |
4
| Karobath Manfred E (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Sold 27,000 shares
@ $7.93, valued at
$214.1k
|
|
| 11/20/2007 |
8-K/A
| Entry into a Material Definitive Agreement, Financial Statements and Exhibits |
| 11/19/2007 |
SC 13G/A
| Xmark Opportunity Partners, LLC reports a 0% stake in COLEY PHARMACEUTICAL GROUP, INC. |
| 11/16/2007 |
8-K
| Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits|
Docs:
|
"Agreement and Plan of Merger, by and among Pfizer, Coley Acquisition Corp., and Coley Pharmaceutical Group, Inc",
"Amendment No. 1, to the Stockholder Rights Agreement, between Coley and Computershare Trust Company, N.A",
"PFIZER TO ACQUIRE COLEY PHARMACEUTICAL GROUP - - -",
"Letter to Employees of Coley" |
|
| 11/02/2007 |
10-Q
| Quarterly Report for the period ended September 30, 2007 |
| 11/01/2007 |
8-K
| Quarterly results |
| 10/09/2007 |
8-K
| Entry into a Material Definitive Agreement, Material Modifications to Rights of Security Holders, Other Events, Financial Sta...|
Docs:
|
"Stockholder Rights Agreement between the Company and Computershare Trust Company, N.A., which includes as Exhibit A, the Summary of Rights to Purchase Common Stock and as Exhibit B, the Form of Rights Certificate",
"Coley Pharmaceutical Group Adopts Shareholder Rights Plan Wellesley, MA, October 8, 2007 - Coley Pharmaceutical Group, Inc. , a biopharmaceutical company discovering and developing a novel class of drug candidates known as TLR Therapeutics™, announced today that its Board of Directors has adopted a Stockholder Rights Plan that is designed to strengthen the ability of the Board of Directors to protect Coley's stockholders. The plan was not adopted in response to any unsolicited offer or takeover attempt. Each stockholder of record of the Company on October 15, 2007, will receive a dividend of one Right for each outstanding share of Common Stock held. Each Right represents the right to purchase, under certain circumstances, one one-hundredth of a share of a new series of preferred stock of t..." |
|
| 09/20/2007 |
4
| Abdalian Charles H Jr (SVP, Finance and CFO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.13, valued at
$125.2k
|
|
| 09/20/2007 |
4
| Bratzler Robert L (President and CEO) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Granted 70,000 options to buy
@ $3.13, valued at
$219.1k
|
|
| 09/20/2007 |
4
| Massari Ferdinand E (Sr. VP of Drug Development) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Granted 65,000 options to buy
@ $3.13, valued at
$203.5k
|
|
| 09/20/2007 |
4
| Krieg Arthur M (SVP, R & D, Chief Scien. Off.) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Granted 55,000 options to buy
@ $3.13, valued at
$172.2k
|
|
| 08/29/2007 |
4
| Krieg Arthur M (SVP, R & D, Chief Scien. Off.) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Sold 21,070 shares
@ $1.89, valued at
$39.8k
|
|
| 08/08/2007 |
10-Q
| Quarterly Report for the period ended June 30, 2007 |
| 08/02/2007 |
8-K
| Quarterly results |
| 07/20/2007 |
SC 13G
| Xmark Opportunity Partners, LLC reports a 5% stake in COLEY PHARMACEUTICAL GROUP, INC. |
| 06/29/2007 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/22/2007 |
8-K
| Other Events, Financial Statements and Exhibits |
| 06/15/2007 |
4
| BATE KENNETH (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Granted 5,459 options to buy
@ $8.02, valued at
$43.8k
|
|
| 06/15/2007 |
4
| HUGIN ROBERT J (Director) has filed a Form 4 on Coley Pharmaceutical Group, Inc.|
Txns:
| Granted 5,459 options to buy
@ $8.02, valued at
$43.8k
|
|
|
|
|